Page last updated: 2024-11-05

tranexamic acid and Atypical Chronic Myeloid Leukemia

tranexamic acid has been researched along with Atypical Chronic Myeloid Leukemia in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Appelmann, I1
Kreher, S1
Parmentier, S1
Wolf, HH1
Bisping, G1
Kirschner, M1
Bergmann, F1
Schilling, K1
Brümmendorf, TH1
Petrides, PE1
Tiede, A1
Matzdorff, A1
Griesshammer, M1
Riess, H1
Koschmieder, S1

Reviews

1 review available for tranexamic acid and Atypical Chronic Myeloid Leukemia

ArticleYear
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis
    Annals of hematology, 2016, Volume: 95, Issue:5

    Topics: Anticoagulants; Antineoplastic Agents; Blood Coagulation Factors; Blood Loss, Surgical; Blood Transf

2016